Méryem-Maud Farhat

494 total citations
15 papers, 107 citations indexed

About

Méryem-Maud Farhat is a scholar working on Pathology and Forensic Medicine, Dermatology and Epidemiology. According to data from OpenAlex, Méryem-Maud Farhat has authored 15 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Dermatology and 4 papers in Epidemiology. Recurrent topics in Méryem-Maud Farhat's work include Systemic Sclerosis and Related Diseases (4 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Chronic Disease Management Strategies (2 papers). Méryem-Maud Farhat is often cited by papers focused on Systemic Sclerosis and Related Diseases (4 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Chronic Disease Management Strategies (2 papers). Méryem-Maud Farhat collaborates with scholars based in France, United States and Mexico. Méryem-Maud Farhat's co-authors include Zoé Van de Wyngaert, Bruno Quesnel, Katarina Jovanović, Salomon Manier, Thierry Façon, É. Hachulla, David Launay, Vincent Sobanski, Sébastien Sanges and S. Morell‐Dubois and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and British Journal of Dermatology.

In The Last Decade

Méryem-Maud Farhat

14 papers receiving 106 citations

Peers

Countries citing papers authored by Méryem-Maud Farhat

Since Specialization

Citations

This map shows the geographic impact of Méryem-Maud Farhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Méryem-Maud Farhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Méryem-Maud Farhat more than expected).

Fields of papers citing papers by Méryem-Maud Farhat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Méryem-Maud Farhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Méryem-Maud Farhat. The network helps show where Méryem-Maud Farhat may publish in the future.

Co-authorship network of co-authors of Méryem-Maud Farhat

This figure shows the co-authorship network connecting the top 25 collaborators of Méryem-Maud Farhat. A scholar is included among the top collaborators of Méryem-Maud Farhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Méryem-Maud Farhat. Méryem-Maud Farhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Rescue therapy in malignant atrophic papulosis: a new era of promising treatments targeting interferon and complement pathways 2025 ·British Journal of Dermatology ·(unknown), (unknown), Méryem-Maud Farhat, (unknown), (unknown), (unknown), (unknown), P. Labalette, D. Staumont‐Sallé, David Launay, É. Hachulla, (unknown)	1
2	Perception of aesthetic impairment in patients with systemic sclerosis determined using a semi-quantitative scale and its association with disease characteristics 2024 ·Journal of Scleroderma and Related Disorders ·Méryem-Maud Farhat, P. Guerreschi, S. Morell‐Dubois, Valérie Deken, Julien Labreuche, Sébastien Sanges, Vincent Sobanski, É. Hachulla, Olivier Cottencin, David Launay	1
3	Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis 2023 ·Scientific Reports ·Silvia Speca, Méryem-Maud Farhat, Manel Jendoubi, Thomas Guerrier, Sébastien Sanges, D. Staumont‐Sallé, É. Hachulla, Sylvain Dubucquoi, Vincent Sobanski, (unknown), David Launay	4
4	Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic? 2023 ·Healthcare ·(unknown), Laurence Guédon-Moreau, David Launay, Louis Terriou, S. Morell‐Dubois, Hélène Maillard, Guillaume Lefèvre, Vincent Sobanski, M. Lambert, Cécile Yelnik, Méryem-Maud Farhat, Maria José Garcia‐Fernandez, É. Hachulla, Sébastien Sanges	0
5	IgG4-related uveitis. A French cohort and literature review 2023 ·Seminars in Arthritis and Rheumatism ·(unknown), B. De Sainte Marie, (unknown), Yves Hatchuel, (unknown), (unknown), G. Pugnet, Matthieu Groh, Méryem-Maud Farhat, (unknown), Mikaël Ebbo, N. Schleinitz	2
6	Tolerance of bradykinin-releasing drugs in patients with acquired C1 inhibitor deficiency: a case series and review of the literature 2022 ·European Journal of Dermatology ·(unknown), (unknown), Louis Terriou, Méryem-Maud Farhat, David Launay, D. Staumont, É. Hachulla, Sophie Gautier, Sébastien Sanges	1
7	Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema 2022 ·Allergy and Asthma Proceedings ·(unknown), (unknown), Sophie Gautier, Méryem-Maud Farhat, (unknown), (unknown), Cécile Yelnik, Sylvain Dubucquoi, (unknown), Manel Jendoubi, (unknown), (unknown), D. Staumont‐Sallé, David Launay, Sébastien Sanges	1
8	Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients 2022 ·Lupus ·Cécile Yelnik, Claire Martin, (unknown), Sébastien Sanges, Vincent Sobanski, Méryem-Maud Farhat, S. Morell‐Dubois, Hélène Maillard, Élodie Drumez, David Launay, É. Hachulla, M. Lambert	11
9	Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis 2022 ·Journal of Clinical Medicine ·(unknown), Thierry Brousseau, S. Morell‐Dubois, Méryem-Maud Farhat, Hélène Maillard, (unknown), M. Lambert, Cécile Yelnik, Sébastien Sanges, Vincent Sobanski, É. Hachulla, David Launay	10
10	Profuse telangiectasias in an immunocompetent patient misleading presentation revealing a hepatosplenic‐Tγδ‐cell lymphoma 2022 ·SHILAP Revista de lepidopterología ·(unknown), Benjamin Carpentier, Romain Dubois, Stéphanie Poulain, (unknown), Louis Terriou, Méryem-Maud Farhat	1
11	Calcinosis in systemic sclerosis 2021 ·Joint Bone Spine ·(unknown), Méryem-Maud Farhat, (unknown), David Launay, É. Hachulla	3
12	Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis 2020 ·Orphanet Journal of Rare Diseases ·Sébastien Sanges, Méryem-Maud Farhat, (unknown), J. Galland, Étienne Rivière, C. Roubille, M. Lambert, Cécile Yelnik, Hélène Maillard, Vincent Sobanski, G. Lefèvre, David Launay, S. Morell‐Dubois, É. Hachulla	10
13	Exploring patient education unmet needs for rare and complex connective tissue and musculoskeletal diseases: A survey of health care providers’ and patients’ expectations in Europe 2020 ·Chronic Illness ·Méryem-Maud Farhat, Alain Cornet, Charissa Frank, Ilaria Galetti, (unknown), (unknown), Ana Vieira, É. Hachulla	5
14	Deregulation and Targeting of TP53 Pathway in Multiple Myeloma 2019 ·Frontiers in Oncology ·Katarina Jovanović, (unknown), (unknown), (unknown), Zoé Van de Wyngaert, Méryem-Maud Farhat, (unknown), Thierry Façon, Bruno Quesnel, Salomon Manier	56
15	Une pseudo-tumeur pancréatique 2015 ·La Revue de Médecine Interne ·Méryem-Maud Farhat, (unknown), C. Baillet, (unknown), (unknown), P.Y. Hatron, É. Hachulla	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact